Targeting Disseminated Estrogen-Receptor-Positive Breast Cancer Cells in Bone Marrow

Estrogen receptor-positive (ER+) breast cancer can recur up to 20 years after initial diagnosis. Delayed recurrences arise from disseminated tumors cells (DTCs) in sites such as bone marrow that remain quiescent during endocrine therapy and subsequently proliferate to produce clinically-detectable m...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncogene
Päätekijät: Buschhaus, Johanna M., Humphries, Brock A., Eckley, Samantha S., Robison, Tanner H., Cutter, Alyssa C., Rajendran, Shrila, Haley, Henry R., Bevoor, Avinash S., Luker, Kathryn E., Luker, Gary D.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7442734/
https://ncbi.nlm.nih.gov/pubmed/32678295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-01391-z
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia